Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
• Ault Alliance, Inc. (NYSE: AULT) gained 73.3% to $5.72 after the company said it anticipates $200 million in annual revenue for 2023.
• Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares climbed 67.3% to $11.34 after the company announced collaboration and a $50 million investment from NVIDIA.
• Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 45.1% to $2.5239 after gaining 15% on Tuesday.
• Liminal BioSciences Inc. (NASDAQ: LMNL) rose 39.6% to $8.31 after the company announced it entered into an arrangement agreement with Structured Alpha LP. Liminal minority shareholders are to receive $8.50 in cash per share in "go private" transaction.
• AVROBIO, Inc. (NASDAQ: AVRO) surged 38.8% to $1.36 after the company announced plans to explore strategic alternatives.
• LivePerson, Inc. (NASDAQ: LPSN) shares climbed 33.7% to $5.70 after the company announced a planned CEO transition.
• InspireMD, Inc. (NYSE: NSPR) gained 31% to $3.03.
• Daktronics, Inc. (NASDAQ: DAKT) rose 30.4% to $7.97 following better-than-expected fourth-quarter results.
• Freeline Therapeutics Holdings plc (NASDAQ: FRLN) shares jumped 28.7% to $4.7759.
• Society Pass Incorporated (NASDAQ: SOPA) gained 23.6% to $0.7490. Ascendiant Capital recently initiated coverage on Society Pass with a Buy rating and announced a price target of $3.5.
• Holley Inc. (NYSE: HLLY) surged 21.6% to $5.35 on positive analyst changes. B of A Securities upgraded the stock and raised its price target from $3.25 to $6, and JP Morgan upgraded the stock from Overweight to Neutral and announced a $7 price target.
• Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 21% to $0.3240 after the company announced FDA Qualified Infectious Disease Product Designation for AR-301.
• Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 20.4% to $9.13. Eloxx Pharmaceuticals shares jumped 94% on Tuesday after Oppenheimer raised its price target from $50 to $55.
• AERWINS Technologies Inc. (NASDAQ: AWIN) jumped 17% to $0.55.
• Centessa Pharmaceuticals plc (NASDAQ: CNTA) rose 15.8% to $8.46. Centessa Pharmaceuticals recently announced dosing of first subject in registrational PRESent-2 study evaluating SerpinPC for the treatment of Hemophilia B without inhibitors.
• EHang Holdings Limited (NASDAQ: EH) gained 13.5% to $17.54. EHang announced a $23 million private placement led by investor Lee Soo Man.
• AbCellera Biologics Inc. (NASDAQ: ABCL) gained 13% to $7.63.
• BitNile Metaverse, Inc. (NASDAQ: BNMV) surged 12.2% to $1.1899.
• Exscientia plc (NASDAQ: EXAI) rose 12% to $7.30. Exscientia recently announced the enrollment of the first patient in the Phase 1/2 "ELUCIDATE" clinical trial assessing GTAEXS617 in advanced solid tumors.
• Domino's Pizza, Inc. (NYSE: DPZ) shares surged 10.2% to $385.54 after the company announced US customers will be able to order through Uber Eats and Postmates.
• Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) gained 9.7% to $2.71.
• Dada Nexus Limited (NASDAQ: DADA) jumped 7.3% to $6.22.

Losers

• PainReform Ltd. (NASDAQ: PRFX) declined 44.5% to $9.00 after the company reported pricing of $2.7 million concurrent registered direct offering and private placement.
• CBL International Limited (NASDAQ: BANL) shares dipped 42.3% to $2.8780 after jumping over 12% on Tuesday.
• Katapult Holdings, Inc. (NASDAQ: KPLT) declined 27% to $0.7150. Katapult’s board approved a 1-for-25 reverse stock split of common stock.
• Silk Road Medical, Inc (NASDAQ: SILK) fell 24.4% to $24.67. Silk Road Medical is expected to report financial results for the second quarter 2023 on Aug. 1, 2023.
• Yellow Corporation (NASDAQ: YELL) dropped 21.5% to $1.0350.
• Gorilla Technology Group Inc. (NASDAQ: GRRR) fell 20% to $4.46.
• T2 Biosystems, Inc. (NASDAQ: TTOO) dropped 20% to $0.1196 as the company reported lower than expected preliminary Q2 sales of $2 million.
• Theratechnologies Inc. (NASDAQ: THTX) declined 19.5% to $0.78 following weak quarterly sales.
• Castle Biosciences, Inc. (NASDAQ: CSTL) fell 19.3% to $15.89.
• Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) fell 17.7% to $4.9655 after surging 42% on Tuesday.
• Crown ElectroKinetics Corp. (NASDAQ: CRKN) fell 16.1% to $0.0913 after gaining around 7% on Tuesday.
• Jupiter Wellness, Inc. (NASDAQ: JUPW) dropped 15.4% to $0.4052. Jupiter Wellness reported postponement of spin-off and distribution of common stock of subsidiary SRM Entertainment.
• Forge Global Holdings, Inc. (NYSE: FRGE) fell 14.7% to $2.43.
• Mullen Automotive, Inc. (NASDAQ: MULN) fell 14.6% to $0.1554.
• Shengfeng Development Limited (NASDAQ: SFWL) dropped 14% to $7.87.
• ShiftPixy, Inc. (NASDAQ: PIXY) fell 13.8% to $2.06 after the company announced pricing of a $3.1 million public offering.
• CytoMed Therapeutics Limited (NASDAQ: GDTC) shares dropped 13.1% to $4.90 after climbing 62% on Tuesday.
• FLJ Group Limited (NASDAQ: FLJ) fell 12.8% to $0.2510.
• Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) shares fell 11.7% to $0.34. Adial Pharmaceuticals shares jumped 90% on Tuesday after the company provided business update following favorable comments from US, EU regulatory meetings.
• Lucid Group, Inc. (NASDAQ: LCID) declined 10.9% to $7.24 after the company announced second-quarter production & deliveries.
• Cingulate Inc. (NASDAQ: CING) fell 10.4% to $0.76. Cingulate recently announced top-line results from its Phase 3 adult efficacy and safety trial of CTx-1301 for ADHD.
• WANG & LEE GROUP, Inc. (NASDAQ: WLGS) shares fell 9.7% to $1.40 after rising over 20% on Tuesday.
• COMPASS Pathways plc (NASDAQ: CMPS) fell 7.5% to $9.30.

Now Read This: Big Trades On Activision Blizzard Stock After Microsoft Wins Acquisition Case